APA

Kölmel K. F., Grange J. M., Krone B., Mastrangelo G., Rossi C. R., Henz B. M., Seebacher C., Botev I. N., Niin M., Lambert D., Shafir R., Kokoschka E., Kleeberg U. R., Gefeller O. & Pfahlberg A. (20050321). Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients. : European journal of cancer (Oxford, England : 1990).

Chicago

Kölmel K F, Grange J M, Krone B, Mastrangelo G, Rossi C R, Henz B M, Seebacher C, Botev I N, Niin M, Lambert D, Shafir R, Kokoschka E-M, Kleeberg U R, Gefeller O and Pfahlberg A. 20050321. Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients. : European journal of cancer (Oxford, England : 1990).

Harvard

Kölmel K. F., Grange J. M., Krone B., Mastrangelo G., Rossi C. R., Henz B. M., Seebacher C., Botev I. N., Niin M., Lambert D., Shafir R., Kokoschka E., Kleeberg U. R., Gefeller O. and Pfahlberg A. (20050321). Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients. : European journal of cancer (Oxford, England : 1990).

MLA

Kölmel K F, Grange J M, Krone B, Mastrangelo G, Rossi C R, Henz B M, Seebacher C, Botev I N, Niin M, Lambert D, Shafir R, Kokoschka E-M, Kleeberg U R, Gefeller O and Pfahlberg A. Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients. : European journal of cancer (Oxford, England : 1990). 20050321.